Illumina Reports Director Departure and Stockholder Meeting

Ticker: ILMN · Form: 8-K · Filed: 2025-05-23T00:00:00.000Z

Sentiment: neutral

Topics: director-departure, stockholder-meeting, corporate-governance

Related Tickers: ILMN

TL;DR

Illumina's board sees a change with Dr. Kahn's exit; stockholders voted on key proposals.

AI Summary

On May 21, 2025, Illumina, Inc. filed an 8-K report detailing several key events. The company announced the departure of director Dr. Scott Kahn, effective May 20, 2025. Additionally, Illumina held its annual meeting of stockholders on May 21, 2025, where proposals were submitted to a vote. The filing also includes information regarding compensatory arrangements for certain officers.

Why It Matters

This filing signals a change in board composition and provides updates on corporate governance matters, which can influence investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing reports routine corporate events like director departures and stockholder meetings, which typically carry low immediate risk.

Key Players & Entities

FAQ

Who is the departing director and when was their departure effective?

Dr. Scott Kahn is the departing director, and his departure was effective May 20, 2025.

What was the date of Illumina's annual meeting of stockholders?

The annual meeting of stockholders was held on May 21, 2025.

What type of corporate events are reported in this 8-K?

This 8-K reports the departure of a director, the submission of matters to a vote of security holders, and information on compensatory arrangements of certain officers.

What is the Commission File Number for Illumina, Inc.?

The Commission File Number for Illumina, Inc. is 001-35406.

What is the principal executive office address for Illumina, Inc.?

The principal executive office address is 5200 Illumina Way, San Diego, CA 92122.

From the Filing

0001110803-25-000051.txt : 20250523 0001110803-25-000051.hdr.sgml : 20250523 20250522175436 ACCESSION NUMBER: 0001110803-25-000051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250521 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250523 DATE AS OF CHANGE: 20250522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 25978502 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 ilmn-20250521.htm 8-K ilmn-20250521 0001110803 FALSE 0001110803 2025-05-22 2025-05-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form  8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware   33-0804655 (State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 )  202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ILMN The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐      If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o      Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The 2025 annual meeting of stockholders (the “Annual Meeting”) of Illumina, Inc. (the “Company”) was held on May 21, 2025. As further described in Item 5.07 below, at the Annual Meeting, stockholders approved the Second Amended and Restated 2015 Stock and Incentive Plan of Illumin

View on Read The Filing